{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T21:57:45Z","timestamp":1772661465169,"version":"3.50.1"},"reference-count":41,"publisher":"The Endocrine Society","issue":"2","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,21]]},"abstract":"Abstract<\/jats:title>\n \n Context<\/jats:title>\n Biochemical screening for endocrine hypertension may be complex; the known presence of an adrenal mass markedly increases the pretest probability for adrenal hypertension and may inform diagnostic efforts.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n Model the potential incidence of adrenal masses that may be detected by routine adrenal imaging in patients with suspected endocrine hypertension.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n Retrospective cohort study.<\/jats:p>\n <\/jats:sec>\n \n Setting<\/jats:title>\n Provincial administrative and clinical databases for radiology and biochemistry, Alberta, Canada.<\/jats:p>\n <\/jats:sec>\n \n Participants<\/jats:title>\n Patients with hypertension and any measurement of aldosterone-renin ratio (ARR), 2012 to 2019.<\/jats:p>\n <\/jats:sec>\n \n Main Measures<\/jats:title>\n Radiology report of any computed tomography or magnetic resonance imaging abdomen performed for any reason 0 to 12 years following ARR. Patients with any pre-ARR imaging data between 2002 and 2024 were excluded. The presence of adrenal mass, size, and density were recorded and stratified by imaging indication.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Of 6942 unique hypertension patients with ARR, 1462 (21%) had imaging done at some point after ARR, 912 (62.4%) for indications unrelated to hypertension\/adrenal and at a median 771 days (69-1577) post ARR. The incidence rate estimate was 7.2% (5.6-9.2%) of scans showed adrenal mass, median 1.4\u2005cm (1.1-2.3), a rate well above the modern series of adrenal incidentaloma prevalence in unselected adults. The number needed to screen in this population was 14 (11-18) to detect an adrenal mass without a priori indication for adrenal imaging.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Among patients screened for PA but without prior or subsequent directed adrenal imaging, 1 in 14 were later found to have an adrenal mass on imaging done for other indications. Given the impact on pretest probability for endocrine hypertension and further investigation steps, routine adrenal imaging might be considered whenever PA suspicion is high.<\/jats:p>\n <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf371","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T07:48:02Z","timestamp":1750492082000},"page":"e535-e540","source":"Crossref","is-referenced-by-count":2,"title":["Incidence of Adrenal Masses Eventually Discovered in Patients Screened for Primary Aldosteronism"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8129-9360","authenticated-orcid":false,"given":"Gregory A","family":"Kline","sequence":"first","affiliation":[{"name":"Department of Medicine, Cumming School of Medicine, University of Calgary , Calgary, AB , T2T 5C7","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9276-5694","authenticated-orcid":false,"given":"Joshua","family":"Low","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dalhousie University , Halifax, NS , B3H 4R2","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2142-7669","authenticated-orcid":false,"given":"Joshua James","family":"Burkart","sequence":"additional","affiliation":[{"name":"Faculty of Kinesiology, University of Calgary , Calgary, AB , T2T 5C7","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6263-8961","authenticated-orcid":false,"given":"Xun Yang","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of British Columbia , Vancouver, BC , V6T 1Z3","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3805-8688","authenticated-orcid":false,"given":"Kaitlyn","family":"Mellor","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of British Columbia , Vancouver, BC , V6T 1Z3","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Przybojewski","sequence":"additional","affiliation":[{"name":"Department of Radiology, Cumming School of Medicine, University of Calgary , Calgary, AB , T2T 5C7","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1332-3610","authenticated-orcid":false,"given":"James","family":"King","sequence":"additional","affiliation":[{"name":"Provincial Research Data Services, Alberta Health Services , Calgary, AB , T2N 4N1","place":["Canada"]},{"name":"Alberta SPOR SUPPORT Unit , Calgary, AB , T2N 4N1","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7536-8497","authenticated-orcid":false,"given":"Alexander A","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cumming School of Medicine, University of Calgary , Calgary, AB , T2T 5C7","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"issue":"4","key":"2026012101520653800_dgaf371-B1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"2026012101520653800_dgaf371-B2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/HYPERTENSIONAHA.115.05702","article-title":"Healthcare costs attributable to hypertension: canadian population-based cohort study","volume":"66","author":"Weaver","year":"2015","journal-title":"Hypertension"},{"issue":"6","key":"2026012101520653800_dgaf371-B3","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1161\/HYPERTENSIONAHA.121.17570","article-title":"Racial\/ethnic disparities in hypertension prevalence, awareness, treatment, and control in the United States, 2013 to 2018","volume":"78","author":"Aggarwal","year":"2021","journal-title":"Hypertension"},{"issue":"12","key":"2026012101520653800_dgaf371-B4","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jama.2020.14545","article-title":"Trends in blood pressure control among US adults with hypertension, 1999-2000 to 2017-2018","volume":"324","author":"Muntner","year":"2020","journal-title":"JAMA\u2014J Am Med Assoc"},{"issue":"9","key":"2026012101520653800_dgaf371-B5","first-page":"51","article-title":"Resistant hypertension\u2014its identification and epidemiology [internet]. vol. 9, nature reviews nephrology","volume":"1","author":"Sarafidis","year":"2013","journal-title":"Nature Publishing Group"},{"issue":"6","key":"2026012101520653800_dgaf371-B6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jash.2014.03.003","article-title":"Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality","volume":"8","author":"Irvin","year":"2014","journal-title":"J Am Soc Hypertens"},{"issue":"12","key":"2026012101520653800_dgaf371-B7","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European society of hypertension endorsed by the European renal association (ERA) and the international society of hypertension (ISH)","volume":"41","author":"Mancia","year":"2024","journal-title":"J Hypertens"},{"issue":"18","key":"2026012101520653800_dgaf371-B8","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/jama.2022.19590","article-title":"Treatment of hypertension: a review","volume":"328","author":"Carey","year":"2022","journal-title":"JAMA"},{"issue":"7","key":"2026012101520653800_dgaf371-B9","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"2026012101520653800_dgaf371-B10","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"2026012101520653800_dgaf371-B11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5694\/mja2.51438","article-title":"Detecting primary aldosteronism in Australian primary care: a prospective study","volume":"216","author":"Libianto","year":"2022","journal-title":"Med J Aust"},{"issue":"1","key":"2026012101520653800_dgaf371-B12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"issue":"6","key":"2026012101520653800_dgaf371-B13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamasurg.2021.0254","article-title":"Outcomes of a specialized clinic on rates of investigation and treatment of primary aldosteronism","volume":"156","author":"Liu","year":"2021","journal-title":"JAMA Surg"},{"issue":"1","key":"2026012101520653800_dgaf371-B14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","article-title":"Renal damage in primary aldosteronism: a systematic review and meta-analysis [internet]","volume":"38","author":"Monticone","year":"2020","journal-title":"J Hypertens"},{"issue":"1","key":"2026012101520653800_dgaf371-B15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2026012101520653800_dgaf371-B16","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026012101520653800_dgaf371-B17","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/clinem\/dgac679","article-title":"Intra-individual variability of Serum aldosterone and implications for primary aldosteronism screening","volume":"108","author":"Maciel","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026012101520653800_dgaf371-B18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1210\/clinem\/dgac568","article-title":"Aldosterone, renin, and aldosterone-to-renin ratio variability in screening for primary aldosteronism","volume":"108","author":"Ng","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026012101520653800_dgaf371-B19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/cen.14409","article-title":"High prevalence and a long delay in the diagnosis of primary aldosteronism among patients with young-onset hypertension","volume":"94","author":"Alam","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2026012101520653800_dgaf371-B20","doi-asserted-by":"crossref","first-page":"e2027","DOI":"10.1210\/clinem\/dgab924","article-title":"The saline infusion test for primary aldosteronism: implications of immunoassay inaccuracy","volume":"107","author":"Eisenhofer","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026012101520653800_dgaf371-B21","doi-asserted-by":"crossref","first-page":"e061671","DOI":"10.1136\/bmjopen-2022-061671","article-title":"I can\u2019t understand why others don\u2019t screen more\u201d: a qualitative study exploring why Australian general practitioners screen for primary aldosteronism","volume":"12","author":"Nainani","year":"2022","journal-title":"BMJ Open"},{"issue":"8","key":"2026012101520653800_dgaf371-B22","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1210\/clinem\/dgab348","article-title":"Performance of the aldosterone to renin ratio as a screening test for primary aldosteronism","volume":"106","author":"Hung","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026012101520653800_dgaf371-B23","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1210\/jc.2018-01041","article-title":"Aldosterone LC-MS\/MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronism","volume":"103","author":"Guo","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026012101520653800_dgaf371-B24","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1007\/s00268-014-2694-9","article-title":"Despite limited specificity, computed tomography predicts lateralization and clinical outcome in primary aldosteronism","volume":"38","author":"Kline","year":"2014","journal-title":"World J Surg"},{"issue":"2","key":"2026012101520653800_dgaf371-B25","first-page":"269","article-title":"Unilateral disease is common in patients with primary aldosteronism without adrenal nodules","volume":"37","author":"Sam","year":"2021","journal-title":"Can J Cardiol"},{"issue":"4","key":"2026012101520653800_dgaf371-B26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/ajh\/hpab195","article-title":"External validation of clinical prediction models in unilateral primary aldosteronism","volume":"35","author":"Sam","year":"2022","journal-title":"Am J Hypertens"},{"issue":"6","key":"2026012101520653800_dgaf371-B27","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1161\/HYPERTENSIONAHA.109.139279","article-title":"Validation of a case definition to define hypertension using administrative data","volume":"54","author":"Quan","year":"2009","journal-title":"Hypertension"},{"issue":"1","key":"2026012101520653800_dgaf371-B28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1530\/EJE-20-0628","article-title":"Epidemiology of pheochromocyoma and paraganglioma: population-based cohort study","volume":"184","author":"Leung","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026012101520653800_dgaf371-B29","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s40618-022-01754-1","article-title":"Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies","volume":"45","author":"Giuffrida","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"2026012101520653800_dgaf371-B30","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1210\/jc.2016-1963","article-title":"Dietary sodium restriction increases the risk of misinterpreting mild cases of primary aldosteronism","volume":"101","author":"Baudrand","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026012101520653800_dgaf371-B31","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1507\/endocrj.EJ19-0262","article-title":"Comparison between the clinical characteristics of patients with adrenal incidentalomas and those with hypertension-associated adrenal tumors in a single center in Japan","volume":"67","author":"Aoe","year":"2020","journal-title":"Endocr J"},{"issue":"1","key":"2026012101520653800_dgaf371-B32","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European network for the study of adrenal tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026012101520653800_dgaf371-B33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41371-017-0011-4","article-title":"The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test","volume":"32","author":"Arruda","year":"2017","journal-title":"J Hum Hypertens"},{"issue":"5","key":"2026012101520653800_dgaf371-B34","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/cen.14861","article-title":"Adrenal incidentaloma: do patients with apparently nonfunctioning mass or autonomous cortisol secretion have similar or different clinical and metabolic features?","volume":"98","author":"Rebelo","year":"2023","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2026012101520653800_dgaf371-B35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/cen.14546","article-title":"Apparent failed and discordant adrenal vein sampling: a potential confounding role of cortisol cosecretion?","volume":"96","author":"Kline","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2026012101520653800_dgaf371-B36","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.7326\/M22-1619","article-title":"Prevalence and characteristics of adrenal tumors in an unselected screening population A cross-sectional study","volume":"175","author":"Jing","year":"2022","journal-title":"Ann Intern Med"},{"issue":"1","key":"2026012101520653800_dgaf371-B37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12020-011-9445-6","article-title":"The prevalence of adrenal incidentaloma in routine clinical practice","volume":"40","author":"Davenport","year":"2011","journal-title":"Endocrine"},{"issue":"1","key":"2026012101520653800_dgaf371-B38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jch.12920","article-title":"Comprehensive first-line magnetic resonance imaging in hypertension: experience from a single-center tertiary referral clinic","volume":"19","author":"Burchell","year":"2017","journal-title":"J Clin Hypertens"},{"issue":"7","key":"2026012101520653800_dgaf371-B39","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1210\/clinem\/dgae039","article-title":"Health care challenges in the management of primary aldosteronism in Southeast Asia","volume":"109","author":"Sukor","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026012101520653800_dgaf371-B40","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.amjmed.2021.03.015","article-title":"Inpatient measurements of urine metanephrines are indistinguishable from pheochromocytoma: retrospective cohort study","volume":"134","author":"Kline","year":"2021","journal-title":"Am J Med"},{"issue":"1","key":"2026012101520653800_dgaf371-B41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jch.14747","article-title":"Multiple radiologist review of adrenal CT still frequently misses lateralized surgical primary aldosteronism","volume":"26","author":"Mah","year":"2024","journal-title":"J Clin Hypertens"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf371\/63551065\/dgaf371.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/2\/e535\/63551065\/dgaf371.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/2\/e535\/63551065\/dgaf371.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:52:19Z","timestamp":1768978339000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/2\/e535\/8171846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6,23]]},"published-print":{"date-parts":[[2026,1,21]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf371","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,6,23]]}}}